RxDoctor Payments Data

Kimberly Hicks

Family · Hilliard, OHNPI 1134536956

Payments from drug & device makers

$5,660in general payments, 2019–2025

Across 405 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$745
  • AstraZeneca$653
  • Novo Nordisk$570
  • Lilly USA, LLC$433
  • Merck$369
  • Pfizer$267
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$5,56398%
  • Education$982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,660 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$41,665
Medicare patients
277
Services billed
1,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol104$116,139
OzempicSemaglutide82$92,926
EliquisApixaban73$83,832
JardianceEmpagliflozin38$41,148
TrulicityDulaglutide16$26,766
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$24,925
JanuviaSitagliptin Phosphate23$22,656
XareltoRivaroxaban24$20,494
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$15,459
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$9,364
LinzessLinaclotide13$7,889
Atorvastatin Calcium422$5,073
Rosuvastatin Calcium327$4,819
Losartan Potassium352$3,628
Metoprolol Succinate213$2,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$653$131,598129 claims
Novo NordiskOzempic$570$92,92682 claims
PfizerEliquis$267$83,83273 claims
Boehringer IngelheimJardiance$76$41,14838 claims
Lilly USA, LLCTrulicity$433$26,76616 claims
GSKTrelegy Ellipta$188$24,92527 claims
MerckJanuvia$369$22,65623 claims
Johnson & JohnsonXarelto$46$20,49424 claims
AbbVieLinzess, Synthroid$745$9,88966 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.

Other family in Hilliard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →